Inabe, Japan

Toru Izuchi




Average Co-Inventor Count = 15.7

ph-index = 1


Location History:

  • Inabe, JP (2017)
  • Kuwana, JP (2017)

Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Toru Izuchi: Innovator in Medical Chemistry

Introduction

Toru Izuchi is a notable inventor based in Inabe, Japan. He has made significant contributions to the field of medical chemistry, particularly through his innovative patents. With a total of 2 patents, Izuchi's work focuses on developing compounds with therapeutic applications.

Latest Patents

Izuchi's latest patents include a 3-azabicyclo[3.1.0]hexane derivative, which is designed for medical purposes. The objective of this invention is to provide a compound that exhibits antagonistic action against μ-opioid receptors, minimizing side effects and enhancing safety. Another significant patent is for a benzoazepine derivative, which has V2 receptor agonistic activity. This compound is intended for use in pharmaceutical compositions, showcasing its potential in medical applications.

Career Highlights

Throughout his career, Toru Izuchi has worked with prominent companies such as Sanwa Kagaku Kenkyusho Co., Ltd. and Ube Industries, Inc. His experience in these organizations has contributed to his expertise in the development of innovative medical compounds.

Collaborations

Izuchi has collaborated with notable coworkers, including Toshiyuki Miyazawa and Daisuke Kurumazuka. These partnerships have likely enhanced his research and development efforts in the field of medical chemistry.

Conclusion

Toru Izuchi's contributions to medical chemistry through his patents reflect his commitment to innovation and safety in pharmaceutical development. His work continues to influence the field and offers promising advancements for medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…